Tci Wealth Advisors, Inc. Eli Lilly & CO Transaction History

Tci Wealth Advisors, Inc.

$1.12 Billion
Q3 2024

A detailed history of Tci Wealth Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Tci Wealth Advisors, Inc. holds 8,196 shares of LLY stock, worth $6.29 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

8,196

Previous 8,157 0.48%

Holding current value

$6.29 Million

Previous $7.39 Million 1.68%

% of portfolio

0.65%

Previous 0.73%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$772.14 - $960.02 $30,113 - $37,440	39 Added 0.48%	8,196 $7.26 Million
Q2 2024 Jul 30, 2024	BUY	$724.87 - $909.04 $8,698 - $10,908	12 Added 0.15%	8,157 $7.39 Million
Q1 2024 May 07, 2024	BUY	$592.2 - $792.28 $26,056 - $34,860	44 Added 0.54%	8,145 $6.34 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $334,546 - $394,385	637 Added 8.53%	8,101 $4.72 Million
Q3 2023 Oct 31, 2023	BUY	$434.7 - $599.3 $4,347 - $5,993	10 Added 0.13%	7,464 $4.01 Million
Q2 2023 Aug 04, 2023	BUY	$350.74 - $468.98 $17,186 - $22,980	49 Added 0.66%	7,454 $3.5 Million
Q1 2023 May 03, 2023	BUY	$310.63 - $364.82 $56,534 - $66,397	182 Added 2.52%	7,405 $2.54 Million
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $21,543 - $25,102	-67 Reduced 0.92%	7,223 $2.64 Million
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $19,271 - $21,961	-65 Reduced 0.88%	7,290 $2.36 Million
Q2 2022 Jul 19, 2022	BUY	$278.73 - $327.27 $166,401 - $195,380	597 Added 8.83%	7,355 $2.39 Million
Q1 2022 Apr 29, 2022	SELL	$234.69 - $291.66 $89,416 - $111,122	-381 Reduced 5.34%	6,758 $1.94 Million
Q4 2021 Jan 24, 2022	SELL	$224.85 - $279.04 $99,158 - $123,056	-441 Reduced 5.82%	7,139 $1.97 Million
Q3 2021 Oct 29, 2021	SELL	$221.6 - $272.71 $103,930 - $127,900	-469 Reduced 5.83%	7,580 $1.75 Million
Q2 2021 Aug 02, 2021	SELL	$180.55 - $233.54 $2,347 - $3,036	-13 Reduced 0.16%	8,049 $1.85 Million
Q1 2021 Apr 29, 2021	SELL	$164.32 - $212.72 $821 - $1,063	-5 Reduced 0.06%	8,062 $1.51 Million
Q4 2020 Jan 21, 2021	SELL	$130.46 - $172.63 $838,596 - $1.11 Million	-6,428 Reduced 44.35%	8,067 $1.36 Million
Q3 2020 Oct 20, 2020	SELL	$146.22 - $169.13 $43,866 - $50,739	-300 Reduced 2.03%	14,495 $2.15 Million
Q2 2020 Jul 20, 2020	BUY	$136.42 - $164.18 $1,637 - $1,970	12 Added 0.08%	14,795 $2.43 Million
Q1 2020 Apr 14, 2020	BUY	$119.05 - $147.35 $245,838 - $304,277	2,065 Added 16.24%	14,783 $2.05 Million
Q4 2019 Jan 27, 2020	BUY	$106.92 - $132.43 $63,082 - $78,133	590 Added 4.86%	12,718 $1.67 Million
Q3 2019 Oct 17, 2019	SELL	$106.79 - $116.16 $8,970 - $9,757	-84 Reduced 0.69%	12,128 $1.36 Million
Q2 2019 Jul 23, 2019	SELL	$110.79 - $129.32 $73,342 - $85,609	-662 Reduced 5.14%	12,212 $1.35 Million
Q1 2019 Apr 11, 2019	SELL	$111.31 - $131.02 $1,892 - $2,227	-17 Reduced 0.13%	12,874 $1.67 Million
Q4 2018 Jan 17, 2019	SELL	$105.9 - $118.64 $67,564 - $75,692	-638 Reduced 4.72%	12,891 $1.49 Million
Q3 2018 Nov 02, 2018	SELL	$85.86 - $107.31 $58,985 - $73,721	-687 Reduced 4.83%	13,529 $1.45 Million
Q2 2018 Jul 27, 2018	SELL	$75.7 - $86.88 $171,460 - $196,783	-2,265 Reduced 13.74%	14,216 $1.21 Million
Q1 2018 Apr 30, 2018	SELL	$74.21 - $87.6 $33,542 - $39,595	-452 Reduced 2.67%	16,481 $1.28 Million
Q4 2017 Feb 01, 2018	BUY	$81.94 - $87.89 $6,145 - $6,591	75 Added 0.44%	16,933 $1.43 Million
Q3 2017 Oct 24, 2017	SELL	$77.07 - $85.54 $38,072 - $42,256	-494 Reduced 2.85%	16,858 $1.44 Million
Q2 2017 Aug 10, 2017	BUY	N/A	17,352	17,352 $1.43 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.

Account

Tci Wealth Advisors, Inc. Eli Lilly & CO Transaction History